Stock Recommendations by Leading Brokers

BofA Securities continues to endorse Reliance Industries with a 'buy' rating, projecting a target price of Rs 1,550, marking a 24% increase. The collaboration with Chinese fast fashion giant Shein is anticipated to significantly boost Reliance's retail revenue and EBITDA, with minimal inventory risks.

Motilal Oswal Financial Services adopts a 'neutral' stance on IRB Infrastructure, setting a target price of Rs 63, up by 19%. The firm's robust order book and promising tender pipeline, especially in BOT projects, are expected to accelerate execution and drive revenue growth and stable margins.

Emkay Global Financial Services recommends a 'buy' for Dixon Technologies, with an ambitious target price of Rs 21,000, reflecting a 45% potential increase. Despite venturing into the semiconductor space, Dixon is expected to maintain its capital efficiency, with a strong outlook in the mobile and IT hardware sectors.

Elara Securities suggests 'accumulate' for Jyothi Labs, with a target price of Rs 450, up by 8%. The company has shown resilience in challenging market conditions, with a strong position in the affordable segment and ongoing distribution expansion expected to sustain volume growth.

Incred Equities maintains a 'hold' on Sun Pharmaceutical Industries, adjusting the target price to Rs 1,900 from Rs 2,000, indicating a 9% potential upside. The firm's specialty portfolio and margin prospects are positive, though FY25F may see moderate earnings due to ongoing investments.

Disclaimer: The opinions and recommendations provided are those of the brokerage firms and do not reflect the views of The Times of India. Always consult with a qualified investment advisor or financial planner before making any investment decisions.